Interim report
Page 1
- 1 - Consolidated Financial Results for the Fiscal Year Ended December 31, 2025 (Under Japanese GAAP) February 13, 2026 Company name CREATE MEDIC CO., LTD. Stock exchange listings：Tokyo Standard Securities code 5187 URL https://www.createmedic.co.jp/english/ Representative Osamu Imazawa President Inquiries Teruya Ueno Executive Officer, Head of Corporate Planning Department Date of general shareholders' meeting (as planned) ：March 27, 2026 Annual securities report filing date (as planned) ：March 26, 2026 Dividend payable date (as planned) ：March 30, 2026 Supplemental material of annual results ：Yes Convening briefing of annual results ：None (Yen amounts are rounded down to millions, unless otherwise noted.) 1. Consolidated financial results for the fiscal year ended December 31, 2025 (from January 1, 2025 to December 31, 2025) (1) Consolidated operating results (Percentages indicate year-on-year changes.) Net sales Operating profit Ordinary profit Profit attributable to owners of parent Fiscal year ended Millions of yen % Millions of yen % Millions of yen % Millions of yen % December 31, 2025 13,617 4.5 1,005 45.1 988 31.7 713 (15.1) December 31, 2024 13,030 3.5 692 (13.8) 750 (14.1) 840 446.0 Note: Comprehensive income For the fiscal year ended December 31, 2025：1,091 Millions of yen ((33.9)%) For the fiscal year ended December 31, 2024：1,652 Millions of yen (198.4%) Basic earnings per share Diluted earnings per share Rate of return on equity Ordinary profit to total assets ratio Operating profit to net sales ratio Fiscal year ended Yen Yen % % % December 31, 2025 84.25 80.75 4.4 4.9 7.4 December 31, 2024 95.41 － 5.5 3.8 5.3 Reference: Investment profit (loss) on equity method For the fiscal year ended December 31, 2025：－ Millions of yen For the fiscal year ended December 31, 2024：－ Millions of yen (2) Consolidated financial position Total assets Net assets Capital adequacy ratio Net assets per share As of Millions of yen Millions of yen % Yen December 31, 2025 20,143 16,332 81.1 1,947.68 December 31, 2024 20,047 15,750 78.6 1,833.67 Reference: Owner's equity As of December 31, 2025 16,331 Millions of yen As of December 31, 2024 15,750 Millions of yen (3) Consolidated cash flows Cash flows from operating activities Cash flows from investing activities Cash flows from financing activities Cash and equivalents, end of period Fiscal year ended Millions of yen Millions of yen Millions of yen Millions of yen December 31, 2025 530 (573) (600) 5,060 December 31, 2024 2,249 270 (877) 5,662
Page 2
- 2 - 2. Cash dividends Dividend per share Total dividend paid Payout ratio (consolidated) Ratio of total amount of dividends to net assets (consolidated) First quarter Second quarter Third quarter Year end Annual Yen Yen Yen Yen Yen Millions of yen % % Fiscal year ended December 31, 2024 － 19.00 － 20.00 39.00 338 40.9 2.2 Fiscal year ended December 31, 2025 － 17.00 － 28.00 45.00 378 53.4 2.4 Fiscal year ending December 31, 2026 (Forecast) － 20.00 － 27.00 47.00 52.5 3. Consolidated financial forecast for the fiscal year ending December 31, 2026 (from January 1, 2026 to December 31, 2026) (Percentages indicate year-on-year changes.) Net sales Operating profit Ordinary profit Profit attributable to owners of parent Basic earnings per share Millions of yen % Millions of yen % Millions of yen % Millions of yen % Yen Six months ending June 30, 2026 6,630 1.0 510 (7.0) 510 (2.9) 357 (13.5) 42.58 Fiscal year ending December 31, 2026 13,960 2.5 1,060 5.5 1,070 8.3 750 5.1 89.44 * Notes (1) Significant changes in the scope of consolidation during the period：None (2) Changes in accounting policies, changes in accounting estimates, and restatement (i) Changes in accounting policies due to revisions to accounting standards and other regulations ：Yes (ii) Changes in accounting policies due to other reasons ：None (iii) Changes in accounting estimates ：None (iv) Restatement ：None (3) Number of issued shares (common shares) ① Number of issued and outstanding shares at the end of fiscal year (including treasury stock) As of December 31, 2025 9,664,327 shares As of December 31, 2024 9,664,327 shares ② Number of treasury stock at the end of fiscal year As of December 31, 2025 1,279,220 shares As of December 31, 2024 1,074,624 shares ③ Average number of shares Fiscal year ended December 31, 2025 8,471,439 shares Fiscal year ended December 31, 2024 8,813,583 shares * Financial results reports are exempt from audit conducted by certified public accountants or an audit firm. * Proper use of earnings forecasts, and other special matters Caution Regarding Forward-Looking Statements: The forward-looking statements contained in this document are based on information currently available to the Company and certain assumptions that the Company deems to be reasonable. They are not intended as a promise by the Company that they will be achieved, and actual results may differ significantly due to various factors.